Emulate

Human biology on a chip.

Boston, United States · Founded 2013 · $203.0M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$203.0M
Last Round
$82.0M Series ESep 2021
Rounds
6

About

Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, spun out of Harvard's Wyss Institute in 2013. The company commercializes its Human Emulation System — microfluidic chips lined with living human cells that replicate organ-level biology — enabling pharmaceutical and biotech researchers to model disease and test drug candidates.

Summary

Emulate is a Biotech company based in Boston, United States, founded in 2013. It has raised $203.0M in total across 6 rounds, most recently a $82.0M Series E round in Sep 2021. Investors include Northpond Ventures, Founders Fund and Alumni Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries ESep 2021
$82.0M

Sign up to see all 6 rounds

Series A through Series E — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Emulate on Indexed.vc
<a href="https://indexed.vc/companies/emulate"><img src="https://indexed.vc/api/badge/company/emulate" alt="Emulate on Indexed.vc" width="260" height="76" /></a>